170 related articles for article (PubMed ID: 15618358)
1. Role of carboxypeptidase E in processing of pro-islet amyloid polypeptide in {beta}-cells.
Marzban L; Soukhatcheva G; Verchere CB
Endocrinology; 2005 Apr; 146(4):1808-17. PubMed ID: 15618358
[TBL] [Abstract][Full Text] [Related]
2. Role of beta-cell prohormone convertase (PC)1/3 in processing of pro-islet amyloid polypeptide.
Marzban L; Trigo-Gonzalez G; Zhu X; Rhodes CJ; Halban PA; Steiner DF; Verchere CB
Diabetes; 2004 Jan; 53(1):141-8. PubMed ID: 14693708
[TBL] [Abstract][Full Text] [Related]
3. The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptide at the NH2-terminal cleavage site.
Wang J; Xu J; Finnerty J; Furuta M; Steiner DF; Verchere CB
Diabetes; 2001 Mar; 50(3):534-9. PubMed ID: 11246872
[TBL] [Abstract][Full Text] [Related]
4. Impaired NH2-terminal processing of human proislet amyloid polypeptide by the prohormone convertase PC2 leads to amyloid formation and cell death.
Marzban L; Rhodes CJ; Steiner DF; Haataja L; Halban PA; Verchere CB
Diabetes; 2006 Aug; 55(8):2192-201. PubMed ID: 16873681
[TBL] [Abstract][Full Text] [Related]
5. Islet prohormone processing in health and disease.
Chen YC; Taylor AJ; Verchere CB
Diabetes Obes Metab; 2018 Sep; 20 Suppl 2():64-76. PubMed ID: 30230179
[TBL] [Abstract][Full Text] [Related]
6. Loss of prohormone convertase 2 promotes beta cell dysfunction in a rodent transplant model expressing human pro-islet amyloid polypeptide.
Courtade JA; Wang EY; Yen P; Dai DL; Soukhatcheva G; Orban PC; Verchere CB
Diabetologia; 2017 Mar; 60(3):453-463. PubMed ID: 27999871
[TBL] [Abstract][Full Text] [Related]
7. Processing of pro-islet amyloid polypeptide in the constitutive and regulated secretory pathways of beta cells.
Marzban L; Trigo-Gonzalez G; Verchere CB
Mol Endocrinol; 2005 Aug; 19(8):2154-63. PubMed ID: 15802374
[TBL] [Abstract][Full Text] [Related]
8. Aberrant processing of human proislet amyloid polypeptide results in increased amyloid formation.
Paulsson JF; Westermark GT
Diabetes; 2005 Jul; 54(7):2117-25. PubMed ID: 15983213
[TBL] [Abstract][Full Text] [Related]
9. Processing of synthetic pro-islet amyloid polypeptide (proIAPP) 'amylin' by recombinant prohormone convertase enzymes, PC2 and PC3, in vitro.
Higham CE; Hull RL; Lawrie L; Shennan KI; Morris JF; Birch NP; Docherty K; Clark A
Eur J Biochem; 2000 Aug; 267(16):4998-5004. PubMed ID: 10931181
[TBL] [Abstract][Full Text] [Related]
10. Processing of pro-islet amyloid polypeptide (proIAPP) by the prohormone convertase PC2.
Badman MK; Shennan KI; Jermany JL; Docherty K; Clark A
FEBS Lett; 1996 Jan; 378(3):227-31. PubMed ID: 8557106
[TBL] [Abstract][Full Text] [Related]
11. Intracellular amyloid-like deposits contain unprocessed pro-islet amyloid polypeptide (proIAPP) in beta cells of transgenic mice overexpressing the gene for human IAPP and transplanted human islets.
Paulsson JF; Andersson A; Westermark P; Westermark GT
Diabetologia; 2006 Jun; 49(6):1237-46. PubMed ID: 16570161
[TBL] [Abstract][Full Text] [Related]
12. Top-Down Proteomics of Mouse Islets With Beta Cell CPE Deletion Reveals Molecular Details in Prohormone Processing.
Fulcher JM; Swensen AC; Chen YC; Verchere CB; Petyuk VA; Qian WJ
Endocrinology; 2023 Nov; 164(12):. PubMed ID: 37967211
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the heparin binding site in the N-terminus of human pro-islet amyloid polypeptide: implications for amyloid formation.
Abedini A; Tracz SM; Cho JH; Raleigh DP
Biochemistry; 2006 Aug; 45(30):9228-37. PubMed ID: 16866369
[TBL] [Abstract][Full Text] [Related]
14. Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation.
Park YJ; Warnock GL; Ao Z; Safikhan N; Meloche M; Asadi A; Kieffer TJ; Marzban L
Diabetes Obes Metab; 2017 May; 19(5):682-694. PubMed ID: 28058779
[TBL] [Abstract][Full Text] [Related]
15. Beta-cell lines derived from transgenic Cpe(fat)/Cpe(fat) mice are defective in carboxypeptidase E and proinsulin processing.
Varlamov O; Fricker LD; Furukawa H; Steiner DF; Langley SH; Leiter EH
Endocrinology; 1997 Nov; 138(11):4883-92. PubMed ID: 9348219
[TBL] [Abstract][Full Text] [Related]
16. Islet amyloid polypeptide: mechanisms of amyloidogenesis in the pancreatic islets and potential roles in diabetes mellitus.
Johnson KH; O'Brien TD; Betsholtz C; Westermark P
Lab Invest; 1992 May; 66(5):522-35. PubMed ID: 1573849
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of glycosaminoglycan-mediated amyloid formation by islet amyloid polypeptide and proIAPP processing intermediates.
Meng F; Raleigh DP
J Mol Biol; 2011 Feb; 406(3):491-502. PubMed ID: 21195086
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression and colocalization of somatostatin, carboxypeptidase-E and prohormone convertases 1 and 2 in rat brain.
Billova S; Galanopoulou AS; Seidah NG; Qiu X; Kumar U
Neuroscience; 2007 Jun; 147(2):403-18. PubMed ID: 17543468
[TBL] [Abstract][Full Text] [Related]
19. Impaired prohormone convertases in Cpe(fat)/Cpe(fat) mice.
Berman Y; Mzhavia N; Polonskaia A; Devi LA
J Biol Chem; 2001 Jan; 276(2):1466-73. PubMed ID: 11038363
[TBL] [Abstract][Full Text] [Related]
20. Amyloidogenicity of recombinant human pro-islet amyloid polypeptide (ProIAPP).
Krampert M; Bernhagen J; Schmucker J; Horn A; Schmauder A; Brunner H; Voelter W; Kapurniotu A
Chem Biol; 2000 Nov; 7(11):855-71. PubMed ID: 11094339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
